Weight changes after menopause can be frustrating and confusing. Is it menopause, aging, sleep, stress, a medication, or something else? Would hormone therapy help with symptoms? Is a weight-management medication worth discussing?

These are reasonable questions to bring to your OB/GYN. Hormone replacement therapy (HRT), also called menopausal hormone therapy, and GLP-1-based medications serve different purposes, work in different ways, and are not right for every patient. This guide explains the basics so you can prepare for a more useful appointment.

Why is it harder to manage weight after menopause?

Midlife weight change usually has several causes rather than one. According to The Menopause Society, aging is a major driver, while the drop in estrogen during menopause can contribute to changes in where the body stores fat, including more storage around the abdomen.

Other changes may add to the difficulty. Muscle mass tends to decline with age. Hot flashes and night sweats can disrupt sleep. Stress, lower activity, and changes in appetite can also play a role. That is why your OB/GYN may want to look at the whole picture, including sleep, blood pressure, blood sugar, cholesterol, and current medications, before discussing treatment.

How GLP-1 medications work

GLP-1 medications act on hormone receptors involved in appetite regulation, food intake, insulin signaling, and how quickly food leaves the stomach. Tirzepatide acts on two receptors, GLP-1 and GIP. Through these effects, the medication category is used in chronic weight-management care for adults who meet specific medical criteria, alongside a reduced-calorie diet and increased physical activity.

Whether a GLP-1 or GLP-1/GIP medication is appropriate depends on your health history, other medications, and treatment goals. That is a decision for you and your prescriber.

When to ask your OB/GYN about HRT

It may be time to ask about HRT when menopause symptoms are affecting your sleep, work, relationships, or daily comfort. Common concerns include hot flashes, night sweats, vaginal dryness, pain with sex, and trouble sleeping. Your visit is also a chance to discuss other possible causes, since not every symptom in midlife is due to menopause.

HRT supplies estrogen, and some patients also need a progestogen. If you still have a uterus, your prescriber will likely discuss whether a progestogen should be used with estrogen to protect the uterine lining. HRT can be delivered in several ways, including oral, transdermal, or local vaginal forms. The hormone, dose, route, and treatment plan depend on your symptoms, medical history, preferences, and clinical assessment.

HRT is not a weight-loss treatment. Never start, stop, or change hormone therapy without talking with your prescriber.

Can you take a GLP-1 medication while on HRT?

HRT and GLP-1-based medications address different needs. HRT is generally discussed for bothersome menopause symptoms. A GLP-1 or GLP-1/GIP medication may be considered for chronic weight management when a patient meets the relevant criteria. Some patients may be candidates for one, both, or neither.

Early research has explored the combination. A 2025 Endocrine Society meeting report described a small observational review of records from 120 postmenopausal women taking tirzepatide. Women who were also using menopause hormone therapy had greater average weight loss than those taking tirzepatide alone. Because the study was small and observational, it does not show that the combination is right for everyone or that HRT causes weight loss. More research is needed, and any decision to combine treatments belongs with your prescriber.

Where compounded HRT fits

ACOG states that FDA-approved menopausal hormone therapies are recommended over compounded bioidentical menopausal hormone therapy when appropriate. A prescriber may still identify an individual situation that requires discussion of a patient-specific preparation, such as an ingredient concern, a needed strength that is not commercially available, or a dosage-form question. The prescriber and pharmacist should review that decision together.

Compounded medications are prepared for an identified individual patient based on a valid prescription. They are not FDA-approved finished drug products and should not be described as safer or more natural than approved products. If your prescriber recommends a patient-specific preparation, your pharmacist can answer questions about how it is prepared, stored, and used.

Questions to bring to your appointment

Before your visit, write down your most disruptive symptoms, when they started, how your sleep and daily life have changed, and your current medications and supplements. You can then ask whether your weight change could be related to menopause, aging, sleep, another condition, or a medication; whether your symptoms are worth discussing in relation to HRT; whether a GLP-1 medication is appropriate; how combined treatment would be monitored if more than one treatment were considered; and what follow-up would be needed.

The goal is not to arrive with a treatment already chosen. It is to give your prescriber enough context to explain your options clearly.

Sources for editorial review

The Menopause Society: Midlife Weight Gain

ACOG: Hormone Therapy for Menopause and Compounded Bioidentical Menopausal Hormone Therapy

FDA: FDA Approves New Medication for Chronic Weight Management

Endocrine Society: Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss